Rep. Matt Gaetz

Maddy summaryThis bill limits funding for the Substance Abuse Prevention program within the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Department of Health and Human Services to $205,469,000 for fiscal year 2024. It directly affects SAMHSA's ability to allocate resources to state and community programs focused on preventing substance abuse. The key provision is a strict spending cap that prevents the program from using more than this specified amount, regardless of other funding authorizations. This is a procedural budgetary measure, not a new policy, and does not alter program eligibility or services.

Maddy summaryHR 1980 sets a funding cap of $5.52 billion for the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly limits the amount of federal funds the NIAID can spend on its programs during that fiscal year. The key provision is a strict dollar limit that prevents the agency from using more than this specified amount, regardless of other funding authorizations. This affects NIAID's budget planning and spending for research and operations in 2024.

Maddy summaryHR 1992 sets a spending cap of $575,579,000 for the National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly limits the available funds for NHGRI's research and operations during 2024, preventing the agency from exceeding this specific dollar amount. The restriction applies to all appropriations authorized for NHGRI under the Department of Health and Human Services budget for that fiscal year.

Maddy summaryThis bill caps funding for the Substance Abuse and Mental Health Services Administration's (SAMHSA) substance abuse treatment program at $3,737,556,000 for fiscal year 2024. It directly affects SAMHSA's ability to allocate resources for substance abuse treatment services under its existing programs. The key provision is a statutory limit preventing the use of funds exceeding this specific amount during FY2024.

Maddy summaryThis bill sets a spending cap of $2.03 billion for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) for fiscal year 2024. It directly affects the NIDDK by limiting its available funding to this specific amount, regardless of other appropriations. The provision is procedural, imposing a budgetary restriction without altering research programs or policies. No other NIH institutes or health programs are impacted by this specific funding limit.

Maddy summaryHR 1991 caps funding for the National Institute of Mental Health (NIMH) within the National Institutes of Health for fiscal year 2024 at $1.81 billion. This bill directly affects NIMH's budget authority, limiting the amount of federal funds it can use for mental health research and programs during FY2024. The provision applies to all funds authorized for NIMH under the Department of Health and Human Services for that fiscal year, preventing increases beyond the specified amount. It is a procedural budgetary measure with no additional policy requirements or changes to mental health services.

Maddy summaryThis bill sets a strict spending cap of $1.525 billion for the Substance Abuse and Mental Health Services Administration's (SAMHSA) Mental Health program in fiscal year 2024. It directly affects SAMHSA's ability to allocate funds for mental health services by prohibiting the use of any amounts exceeding this specific limit. The key mechanism is a mandatory funding ceiling that applies regardless of other existing laws or authorizations. This is a procedural budget constraint, not a policy change, limiting available resources for mental health programs without altering their structure or eligibility.

Maddy summaryHR 1990 sets a maximum funding limit of $1.42 billion for the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly restricts the budget available to NIDA for drug abuse research and related programs during FY2024. The provision explicitly prohibits NIDA from accessing funds exceeding this specified amount, regardless of other funding authorizations. This is a procedural budget constraint, not a substantive policy change to drug abuse treatment or research.

This bill limits FY2024 funding for the National Institutes of Health for the CURES Act Innovation Account. (This account provides multiyear funding for specific scientific initiatives, including the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative and the Cancer Moonshot.)

Maddy summaryHR 1977 sets a funding cap of $461,781,000 for the National Institutes of Dental and Craniofacial Research (NIDCR) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly limits the amount of federal funds the NIDCR can use for its operations and research during that fiscal year. The provision prevents the NIDCR from accessing more than this specific amount, regardless of other authorized appropriations. It affects the NIDCR’s budget authority but does not create new programs or alter existing research priorities.